If one insurer views you as risky or just doesn't want to compete for your custom, then even its lowest offers are likely to be pricier than policies from other providers, which could also provide ...
Larger studies are needed to assess efficacy, but early data suggest this approach could offer a less toxic alternative to CAR-T cell therapies that are approved by the Food and Drug ...
Credit: Mongkolchon Akesin/Shutterstock. Umoja Biopharma has announced the closing of an oversubscribed $100m Series C financing round, which will enable the company to progress its in vivo chimeric ...
Umoja Biopharma has announced the closing of an oversubscribed $100m Series C financing round, which will enable the company to progress its in vivo chimeric antigen receptor (CAR)-T cell therapy ...
If you don’t care about using your car seat as an infant carrier, you can choose to skip the bucket seat completely. The main trade-off is that you’ll save money on replacing a bucket seat ...
Instead, the biotech focused on UB-VV400, an off-the-shelf, multidomain fusion protein surface-engineered lentiviral vector designed to generate CD22-directed CAR T cells within a patient’s body.
1 CAR T therapies are a personalized approach to treating certain blood cancers, using a patient’s own T cells that are “reprogrammed” to recognize and attack cancer cells. This therapy is often a one ...
T-Mobile is one of the fastest-growing carriers in the United States thanks to aggressive pricing, marketing, and a penchant for doing the unexpected. The Uncarrier has significantly shaken up the ...